Results 21 to 30 of about 34,497 (254)

Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone

open access: yesFrontiers in Pharmacology, 2023
Renal sodium retention is an essential indicator that is used for the prognosis of cirrhosis with ascites that requires diuretic treatment to restore sodium homeostasis.
Tun-Pin Hsueh   +5 more
doaj   +1 more source

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure

open access: yesArquivos Brasileiros de Cardiologia, 2015
Background: Matrix metalloproteinases (MMPs) are a family of enzymes important for the resorption of extracellular matrices, control of vascular remodeling and repair.
João Pedro Ferreira   +5 more
doaj   +1 more source

Efficacy and Safety of Spironolactone in the Treatment of Resistant Hypertension:a Meta-analysis [PDF]

open access: yesZhongguo quanke yixue, 2022
BackgroundAs a special type of hypertension, resistant hypertension has complex etiology, is difficult to treat, and more likely to lead to target organ damage.
ZHANG Ping, ZOU Jing, GAO Cunzhou, WU Aiping, LI Rongshan
doaj   +1 more source

Unexpected Antiviral Activity of Spironolactone

open access: yes, 2020
Epstein-Barr virus (EBV) is a human herpesvirus associated with clinical infections and several types of malignancies. Sankar Swaminathan, MD, and colleagues showed that a hypertension/heart failure drug, spironolactone, also has anti-EBV effects.
Swaminathan, S.; Verma, D.
core   +1 more source

Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program

open access: yesInternational Journal of Women's Dermatology, 2019
Purpose: The necessity of serum potassium monitoring for healthy women who are prescribed spironolactone for acne has been debated. The aim of this study was to compare the incidence of hyperkalemia in women 18 to 45 years of age to that in women 46 to ...
Rebecca M. Thiede   +6 more
doaj   +1 more source

ALDO-study - Spironolactone and arrhythmia in hemodialysis [Cardiovascular effects of spironolactone in hemodialysis]

open access: yes, 2020
This is a study of the effects of mineralocorticoid receptor blocker Spironolactone on cardiovasular function in persons with End-Stage Renal disease on hemodialysis treatment.
Michael Eklund   +2 more
core   +1 more source

SPIRONOLACTONE IN FIRST-LINE ANTIHYPERTENSIVE THERAPY: EFFECT ON VASCULAR REMODELING [PDF]

open access: yes, 2023
Introduction. Previously, clinical studies have proven a pronounced antihypertensive effect of spironolactone in patients with true resistant hypertension.
Anna Mikhailovna Torunova
core   +1 more source

Spironolactone in dermatology:uses in acne and beyond

open access: yes, 2020
Spironolactone is a synthetic aldosterone receptor antagonist, with a role off-label in various dermatological conditions. Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and ...
Searle, T. N.   +2 more
core   +1 more source

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: The feasibility of spironolactone withdrawal in dilated cardiomyopathy patients with improved ejection fraction remains unknown. This study sought to determine whether spironolactone can be withdrawn safely in this circumstance.Methods ...
Yanjia Chen   +10 more
doaj   +1 more source

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study

open access: yes, 2006
BACKGROUND: The beneficial effects of beta-blockers and aldosterone receptor antagonists are now well established in patients with severe systolic chronic heart failure (CHF).
Rouleau, Jean-Lucien   +18 more
core   +2 more sources

Home - About - Disclaimer - Privacy